San Francisco-based preclinical biotech Senti Biosciences is selling off a manufacturing facility to a private equity firm that’s spinning it into a new contract manufacturer known as GeneFab.
Senti said Thursday it will sublease its recently constructed, 92,000-square-foot manufacturing facility in Alameda, CA, to GeneFab, which is backed by Celadon…
Click here to view original post
